for the Brazilian Wilms' Tumor Study Group$ Background. To verify the adequacy of a simplified chemotherapeutic regimen for the treatment of Wilms' tumor (WT), the authors conducted a clinical trial to compare the standard fractionated dose (15 mcg/kg x 5 days) of dactinomycin (AMD) with a single do
โฆ LIBER โฆ
Single-dose versus fractionated-dose dactinomycin in the treatment of wilms' tumor. Preliminary results of a clinical trial
โ Scribed by Beatriz De Camargo; Eduardo L. Franco; The Brazilian Wilms' Tumor Study Group
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 685 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A randomized clinical trial of single-do
โ
Beatriz De Camargo; Eduardo L. Franco; Brazilian Wilms' Tumor Study Group
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 500 KB
Severe hepatic toxicity after treatment
โ
Daniel M. Green; Jerry Z. Finklestein; Patricia Norkool; Giulio J. D'Angio
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 416 KB
๐ 2 views
Preoperative versus postoperative radiot
โ
J. Lemerle; P. A. Voute; M. F. Tournade; J. F. M. Delemarre; B. Jereb; L. Ahstro
๐
Article
๐
1976
๐
John Wiley and Sons
๐
English
โ 570 KB
Results of a randomized clinical trial o
โ
C. Vandenbrouck; H. Sancho; R. Le Fur; J. M. Richard; Y. Cachin
๐
Article
๐
1977
๐
John Wiley and Sons
๐
English
โ 307 KB
๐ 2 views
Dose-ranging study of mesalamine (PENTAS
โ
Dr. Stephen B. Hanauer
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 490 KB
The safety and efficacy of mesalamine enemas were determined in a dose-ranging study enrolling 287 patients with ulcerative proctitis and proctosigmoiditis in a doubleblind, placebo-controlled, multicenter trial. Patients were randomized to receive placebo, 1, 2, or 4 g in 100 ml mesalamine (PENTASA
Low-dose methotrexate compared with azat
โ
H. Hamdy; R. J. R. McKendry; E. Mierins; J. A. Liver
๐
Article
๐
1987
๐
John Wiley and Sons
๐
English
โ 745 KB